Two Treatment Regimens of Cocamide DEA Lotion for Head Lice
NCT02499549 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 112
Last updated 2015-07-16
Summary
To assess the efficacy and safety of 10% Cocamide DEA using two treatment regimens in the eradication of head lice. To assess the ability of each treatment regimen to kill all viable ova and to assess patient acceptability of the product in use
Conditions
- Pediculosis
- Head Louse Infestation
Interventions
- DRUG
-
cocamide diethanolamine
10% Cocamide DEA aqueous lotion is applied directly to dry hair and is washed off with water only
Sponsors & Collaborators
-
Riemann a/s
collaborator UNKNOWN -
Medical Entomology Centre
lead INDUSTRY
Principal Investigators
-
Ian F Burgess · Medical Entomology Centre
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 4 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1999-10-31
- Primary Completion
- 1999-12-31
- Completion
- 1999-12-31
More Related Trials
-
Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis
NCT03514511 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis
NCT00690833 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis
NCT02749383 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult
NCT03830177 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis
NCT02118792 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis
NCT03250624 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study in Subjects With Seborrheic Dermatitis
NCT01703793 ·Status: COMPLETED ·Phase: PHASE2
-
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
NCT02949960 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102
NCT01423656 ·Status: COMPLETED ·Phase: PHASE1
-
Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis
NCT00125333 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis
NCT01782729 ·Status: COMPLETED ·Phase: PHASE4
-
LEO 29102 Single and Multiple Dose Study by Dermal Application
NCT00891709 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis
NCT05923099 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic Dermatitis
NCT00583895 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis
NCT02748993 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis
NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
NCT02864498 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis
NCT01005823 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis
NCT01828879 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
NCT02594969 ·Status: COMPLETED ·Phase: NA
-
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
NCT03796676 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
NCT01232985 ·Status: COMPLETED ·Phase: PHASE2
-
0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis
NCT02241174 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
NCT01447758 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis
NCT00465699 ·Status: UNKNOWN ·Phase: NA